연구성과로 돌아가기
2021 연구성과별 연구자 정보 (1307 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Liolophura species discrimination with geographical distribution patterns and their divergence and expansion history on the northwestern Pacific coast | Hwang, Ui Wook | Hwang, UW | 7 | 교신저자 | Kyungpook Natl Univ, Inst Korean Herb Bio Convergence Promot, Daegu 41566, South Korea | uwhwang1@gmail.com; | ||||
| Liolophura species discrimination with geographical distribution patterns and their divergence and expansion history on the northwestern Pacific coast | Hwang, Ui Wook | Hwang, UW | 7 | 교신저자 | Kyungpook Natl Univ, Sch Life Sci, Grad Sch, Daegu 41566, South Korea | uwhwang1@gmail.com; | ||||
| Liolophura species discrimination with geographical distribution patterns and their divergence and expansion history on the northwestern Pacific coast | Hwang, Ui Wook | Hwang, UW | 7 | 교신저자 | Kyungpook Natl Univ, Sch Ind Technol Adv, Daegu 41566, South Korea | uwhwang1@gmail.com; | ||||
| Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond | Bhusal, Anup | Bhusal, A | 1 | Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu, South Korea | ksuk@knu.ac.kr; | |||||
| Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond | Bhusal, Anup | Bhusal, A | 1 | Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 Plus KNU Biomed Convergence Program, Daegu, South Korea | ksuk@knu.ac.kr; | |||||
| Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond | Lee, Won-Ha | Lee, WH | 2 | Kyungpook Natl Univ, Sch Life Sci, BK21 FOUR KNU Creat BioRes Grp, Daegu, South Korea | ksuk@knu.ac.kr; | |||||
| Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond | Suk, Kyoungho | Suk, K | 3 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu, South Korea | ksuk@knu.ac.kr; | ||||
| Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond | Suk, Kyoungho | Suk, K | 3 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 Plus KNU Biomed Convergence Program, Daegu, South Korea | ksuk@knu.ac.kr; | ||||
| Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond | Suk, Kyoungho | Suk, K | 3 | 교신저자 | Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea | ksuk@knu.ac.kr; | ||||
| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | Yoo, Changhoon | Yoo, C | 1 | 교신저자 | Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea | yooc@amc.seoul.kr; | ||||
| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | Kim, Kyu-Pyo | Kim, KP | 2 | Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea | GQH-5608-2022 | Kim, Hyunho | yooc@amc.seoul.kr; | |||
| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | Jeong, Jae Ho | Jeong, JH | 3 | Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea | yooc@amc.seoul.kr; | |||||
| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | Kim, Ilhwan | Kim, I | 4 | Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Oncol,Coll Med, Busan, South Korea | AGF-2385-2022 | Kim, In-Ryoung | yooc@amc.seoul.kr; | |||
| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | Kang, Myoung Joo | Kang, MJ | 5 | Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Oncol,Coll Med, Busan, South Korea | yooc@amc.seoul.kr; | |||||
| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | Cheon, Jaekyung | Cheon, J | 6 | Univ Ulsan, Asan Med Ctr, Ulsan Univ Hosp, Coll Med, Seoul, South Korea | yooc@amc.seoul.kr; |
페이지 이동: